Essling Expansion, the private equity fund specialized in small and medium capitalization of Essling Capital, invests 16 million euros to enter Evolucare’s capital. This operation is combined with a financial debt of 10 million euros. This should provide this SME with the means to « accelerate its development » as the President Elie Le Guilcher comments, by strengthening its research as well as its international strategy.
This fund raising should allow Evolucare to grow its business abroad from 10% today to 50% in 5 years time to reach a total of 70 million euros turnover.
This should also give Evolucare the means to grow externally. Indeed, even though the healthcare IT market is still very fragmented, it tends to consolidate under the regulatory pressure. Hence, Evolucare will primarily target profitable SME in its future acquisitions. « With our support, Evolucare will be able to consolidate its position in the French market as well as in the international market », underlines Rémi Matuchansky, co-manager of Essling Expansion.